Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer
2016 · PLoS Genetics · 265 citations
https://doi.org/10.1371/journal.pgen.1005895
C
Chris Morehouse
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
3.3K
Citations
27
h-index
34
i10-index
Chris Morehouse is an academic researcher from AstraZeneca (Netherlands). The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & T-cell and B-cell Immunology & Ferroptosis and cancer prognosis. The author has an h-index of 27, co-authored 64 publications.
Papers by this author
worksA phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
2013 · Annals of the Rheumatic Diseases · 162 citations
https://doi.org/10.1136/annrheumdis-2012-202794
Altered Expression of Insulin Receptor Isoforms in Breast Cancer
2011 · PLoS ONE · 61 citations
https://doi.org/10.1371/journal.pone.0026177
Autoimmune manifestations in aged mice arise from early-life immune dysregulation
2016 · Science Translational Medicine · 51 citations
https://doi.org/10.1126/scitranslmed.aag0367
Genomic signatures characterize leukocyte infiltration in myositis muscles
2012 · BMC Medical Genomics · 40 citations
https://doi.org/10.1186/1755-8794-5-53
High-throughput RNA sequencing reveals distinct gene signatures in active IgG4-related disease
2017 · Scientific Reports · 12 citations
https://doi.org/10.1038/s41598-017-17602-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat